218 related articles for article (PubMed ID: 21980496)
1. Tumor necrosis factor α-converting enzyme inhibition reverses hepatic steatosis and improves insulin sensitivity markers and surgical outcome in mice.
de Meijer VE; Le HD; Meisel JA; Sharma AK; Popov Y; Puder M
PLoS One; 2011; 6(9):e25587. PubMed ID: 21980496
[TBL] [Abstract][Full Text] [Related]
2. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
3. Broad-spectrum matrix metalloproteinase inhibition curbs inflammation and liver injury but aggravates experimental liver fibrosis in mice.
de Meijer VE; Sverdlov DY; Popov Y; Le HD; Meisel JA; Nosé V; Schuppan D; Puder M
PLoS One; 2010 Jun; 5(6):e11256. PubMed ID: 20593020
[TBL] [Abstract][Full Text] [Related]
4. Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice.
Menghini R; Menini S; Amoruso R; Fiorentino L; Casagrande V; Marzano V; Tornei F; Bertucci P; Iacobini C; Serino M; Porzio O; Hribal ML; Folli F; Khokha R; Urbani A; Lauro R; Pugliese G; Federici M
Gastroenterology; 2009 Feb; 136(2):663-72.e4. PubMed ID: 19027012
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats.
Li S; Liao X; Meng F; Wang Y; Sun Z; Guo F; Li X; Meng M; Li Y; Sun C
PLoS One; 2014; 9(1):e86724. PubMed ID: 24489777
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of matrix metalloproteinases increases PPAR-alpha and IL-6 and prevents dietary-induced hepatic steatosis and injury in a murine model.
Alwayn IP; Andersson C; Lee S; Arsenault DA; Bistrian BR; Gura KM; Nose V; Zauscher B; Moses M; Puder M
Am J Physiol Gastrointest Liver Physiol; 2006 Dec; 291(6):G1011-9. PubMed ID: 16844679
[TBL] [Abstract][Full Text] [Related]
7. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
Liu LF; Purushotham A; Wendel AA; Belury MA
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
[TBL] [Abstract][Full Text] [Related]
8. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
9. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease.
Li Z; Yang S; Lin H; Huang J; Watkins PA; Moser AB; Desimone C; Song XY; Diehl AM
Hepatology; 2003 Feb; 37(2):343-50. PubMed ID: 12540784
[TBL] [Abstract][Full Text] [Related]
10. Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice.
Huang J; Jia Y; Fu T; Viswakarma N; Bai L; Rao MS; Zhu Y; Borensztajn J; Reddy JK
FASEB J; 2012 Feb; 26(2):628-38. PubMed ID: 22009939
[TBL] [Abstract][Full Text] [Related]
11. Fenretinide ameliorates insulin resistance and fatty liver in obese mice.
Koh IU; Jun HS; Choi JS; Lim JH; Kim WH; Yoon JB; Song J
Biol Pharm Bull; 2012; 35(3):369-75. PubMed ID: 22382323
[TBL] [Abstract][Full Text] [Related]
12. A novel aminosterol reverses diabetes and fatty liver disease in obese mice.
Takahashi N; Qi Y; Patel HR; Ahima RS
J Hepatol; 2004 Sep; 41(3):391-8. PubMed ID: 15336441
[TBL] [Abstract][Full Text] [Related]
13. Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis.
Monsénégo J; Mansouri A; Akkaoui M; Lenoir V; Esnous C; Fauveau V; Tavernier V; Girard J; Prip-Buus C
J Hepatol; 2012 Mar; 56(3):632-9. PubMed ID: 22037024
[TBL] [Abstract][Full Text] [Related]
14. Piperine reverses high fat diet-induced hepatic steatosis and insulin resistance in mice.
Choi S; Choi Y; Choi Y; Kim S; Jang J; Park T
Food Chem; 2013 Dec; 141(4):3627-35. PubMed ID: 23993530
[TBL] [Abstract][Full Text] [Related]
15. Conjugated linoleic acid fails to worsen insulin resistance but induces hepatic steatosis in the presence of leptin in ob/ob mice.
Wendel AA; Purushotham A; Liu LF; Belury MA
J Lipid Res; 2008 Jan; 49(1):98-106. PubMed ID: 17906221
[TBL] [Abstract][Full Text] [Related]
16. The therapeutic effects of resveratrol on hepatic steatosis in high-fat diet-induced obese mice by improving oxidative stress, inflammation and lipid-related gene transcriptional expression.
Cheng K; Song Z; Zhang H; Li S; Wang C; Zhang L; Wang T
Med Mol Morphol; 2019 Dec; 52(4):187-197. PubMed ID: 30673851
[TBL] [Abstract][Full Text] [Related]
17. Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach.
Hookman P; Barkin JS
Am J Gastroenterol; 2003 Sep; 98(9):2093-7. PubMed ID: 14499793
[TBL] [Abstract][Full Text] [Related]
18. A critical role for matrix metalloproteinases in liver regeneration.
Alwayn IP; Verbesey JE; Kim S; Roy R; Arsenault DA; Greene AK; Novak K; Laforme A; Lee S; Moses MA; Puder M
J Surg Res; 2008 Apr; 145(2):192-8. PubMed ID: 18222481
[TBL] [Abstract][Full Text] [Related]
19. Repetitive orogastric gavage affects the phenotype of diet-induced obese mice.
de Meijer VE; Le HD; Meisel JA; Puder M
Physiol Behav; 2010 Jun; 100(4):387-93. PubMed ID: 20385157
[TBL] [Abstract][Full Text] [Related]
20. Effects of bile acid sequestration on hepatic steatosis in obese mice.
Solís N; Pizarro M; Quintero P; Arab JP; Riquelme A; Padilla O; Carrasco G; Pirola CJ; Sookoian S; Arrese M
Ann Hepatol; 2013 Jan-2014 Feb; 13(1):105-12. PubMed ID: 24378273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
